StreetInsider.com News Articles

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, announces that the Geneva Court of First Instance, in a ruling notified on January 28, 2026, considered there was no ground to extend the definitive debt moratorium and, as a result, has declared GeNeuro SA bankrupt.

As previously announced, GeNeuro SA had obtained on September 26, 2025, a definitive debt-restructuring moratorium of four months, expiring on January 27, 2026, to allow GeNeuro SA to further its efforts to evaluate all available options, including recapitalization, advancing and/or

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Announces the End of the Debt Moratorium and the Commencement of Bankruptcy Proceedings

Wed, 28 Jan 2026 02:52:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

GeNeuro (Euronext Paris: CH0308403085 - GNRO), has requested Euronext Paris to suspend trading of its shares (ISIN: CH0308403085) as of the opening of markets on Friday, January 23, 2026, pending the publication of a press release announcing the judgment of the Geneva Court of First Instance concerning its debt moratorium.

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Requests Temporary Suspension of Trading of Its Shares on Euronext Paris

Fri, 23 Jan 2026 04:59:00 -0400

GENEVA, Switzerland--(BUSINESS WIRE)-- Regulatory News:

As previously announced, on September 26, 2025, GeNeuro SA obtained a four-month extension of its definitive moratorium until January 27, 2026.

The ruling of the Geneva Court of First Instance is expected on Tuesday, January 27, 2026; it will be published in the Official Gazette

GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report

Wed, 15 Oct 2025 14:25:00 -0400

GENEVA--(BUSINESS WIRE)-- Regulatory News:

GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces the postponement of its June 30, 2025 half-yearly results and half-yearly financial report. This decision is in line with the postponement of the annual results for the fiscal year ended December 31, 2024, annual results and annual financial report in order to be able to take into account the financial impacts of the restructuring targeted by the Company as part of the debt-restructuring moratorium procedure extended on September 25, 2025. The Company will announce by press